Cours Curis, Inc. Nasdaq
Actions
US2312691015
Recherche biotechnologique et médicale
CA 2024 * | 8,61 M 7,86 M | CA 2025 * | 8,96 M 8,18 M | Capitalisation | 85,29 M 77,87 M |
---|---|---|---|---|---|
Résultat net 2024 * | -49 M -44,74 M | Résultat net 2025 * | -54 M -49,3 M | VE / CA 2024 * | 9,9 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 9,52 x |
PER 2024 * |
-2,33
x | PER 2025 * |
-2,81
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,82% |
Dernier transcript sur Curis, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 29/03/16 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 26/07/22 |
Chief Tech/Sci/R&D Officer | - | 03/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/11/03 | |
Chairman | 82 | 14/02/00 | |
James Dentzer
CEO | Chief Executive Officer | 57 | 29/03/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |